Blab AI
Autonomize AI Expands Advisory Board and Adds Transformation Lead to Drive Enterprise-Scale AI Adoption
On June 10 2026, Autonomize AI—an enterprise intelligence platform powering U.S. health systems—announced that it has broadened its advisory board and created a new Head of Transformation role. The move brings three senior leaders—Dr. Brian Anderson, Bill Fandrich and Keith Reynolds—into the board and adds Mike Longacre to oversee the company’s transformation practice.
The announcement follows a period of rapid growth for Autonomize, which has been named a 2026 World Economic Forum Technology Pioneer and has secured backing from Valtruis, Asset Management Ventures, Cigna Group Ventures, ATX Venture Partners and TAU Ventures. The company’s platform is used by three of the five largest U.S. health enterprises to orchestrate AI‑driven workflows in utilization management, care coordination, prior authorization and revenue cycle operations.
“Healthcare organizations increasingly recognize that AI success requires far more than deploying models or automating individual tasks,” said Ganesh Padmanabhan, CEO and co‑founder of Autonomize. “Real transformation happens when AI is embedded into the fabric of how work gets done across clinical, operational and administrative functions. With the addition of these exceptional leaders, we’re strengthening our ability to help customers navigate both the technology and the organizational changes required to achieve AI at scale.” The statement underscores the company’s focus on operationalizing AI rather than merely experimenting with it.
The new advisory board members bring deep experience in responsible AI, health policy and large‑scale transformation. Dr. Anderson is CEO and co‑founder of the Coalition for Health AI (CHAI), an industry group that develops consensus‑based frameworks for trustworthy AI in healthcare. Bill Fandrich has a four‑decade record in business transformation, analytics and AI across healthcare and financial services, and Keith Reynolds is the chief operating officer of Welldoc and a former CVS Health executive who has led AI commercialization initiatives.
“Healthcare’s AI future depends on building systems that organizations can trust and scale responsibly,” Anderson said. “Autonomize has demonstrated a strong commitment to applying AI in ways that create meaningful value while supporting transparency, governance and accountability. I’m excited to contribute to that mission.”
Fandrich highlighted the need for reimagining business processes around intelligence. “The greatest opportunities won’t come from isolated technology deployments, but from reimagining business processes and operating models around intelligence,” he said. Reynolds added that AI must be integrated into everyday workflows in ways that are practical, scalable and measurable.
Mike Longacre, who joins Autonomize as Head of Transformation, has led enterprise modernization and AI strategy for payers and technology firms, including roles at PwC’s Health Transformation practice, UnitedHealthcare and ConnectureDRX. The new position is intended to help customers accelerate enterprise‑wide adoption, align technology initiatives with business priorities and unlock the full value of AI‑driven transformation.
“Many organizations know where they want to go with AI, but the path from pilot to enterprise‑wide transformation remains challenging,” Longacre said. “Success requires aligning people, processes, governance, technology and culture around a shared vision. I’m excited to help our customers unlock the full potential of AI by translating innovation into sustainable operational change.”
Autonomize’s platform is described as an AI operating layer built exclusively for healthcare enterprises, offering AI agents, workflow intelligence and domain expertise. The company emphasizes enterprise‑grade governance, security, compliance and explainability, and positions itself as a bridge between fragmented data and institutional knowledge.
The expansion of the advisory board and the creation of the Head of Transformation role signal Autonomize’s commitment to the next phase of AI in healthcare, which the company views as defined by responsible, scalable and measurable operationalization rather than by technological novelty alone.
At present, Autonomize continues to develop its platform, with recent updates to the Knowledge Center and the release of version 3 of its Intelligence Platform. The company’s leadership team remains focused on helping health systems move beyond pilots and achieve measurable clinical, operational and financial impact from AI investments.
The company’s latest moves come amid a broader industry push to embed AI into core operations, as payers and providers face mounting pressure to improve efficiency, reduce administrative burden and enhance patient outcomes. Autonomize’s expanded leadership team and new transformation role aim to address the gap between AI innovation and real‑world impact.
As the healthcare sector seeks to scale AI responsibly, Autonomize’s expanded advisory board and transformation leadership position the company to guide organizations through the complex journey from experimentation to enterprise‑wide adoption.
The announcement follows a period of rapid growth for Autonomize, which has been named a 2026 World Economic Forum Technology Pioneer and has secured backing from Valtruis, Asset Management Ventures, Cigna Group Ventures, ATX Venture Partners and TAU Ventures. The company’s platform is used by three of the five largest U.S. health enterprises to orchestrate AI‑driven workflows in utilization management, care coordination, prior authorization and revenue cycle operations.
“Healthcare organizations increasingly recognize that AI success requires far more than deploying models or automating individual tasks,” said Ganesh Padmanabhan, CEO and co‑founder of Autonomize. “Real transformation happens when AI is embedded into the fabric of how work gets done across clinical, operational and administrative functions. With the addition of these exceptional leaders, we’re strengthening our ability to help customers navigate both the technology and the organizational changes required to achieve AI at scale.” The statement underscores the company’s focus on operationalizing AI rather than merely experimenting with it.
The new advisory board members bring deep experience in responsible AI, health policy and large‑scale transformation. Dr. Anderson is CEO and co‑founder of the Coalition for Health AI (CHAI), an industry group that develops consensus‑based frameworks for trustworthy AI in healthcare. Bill Fandrich has a four‑decade record in business transformation, analytics and AI across healthcare and financial services, and Keith Reynolds is the chief operating officer of Welldoc and a former CVS Health executive who has led AI commercialization initiatives.
“Healthcare’s AI future depends on building systems that organizations can trust and scale responsibly,” Anderson said. “Autonomize has demonstrated a strong commitment to applying AI in ways that create meaningful value while supporting transparency, governance and accountability. I’m excited to contribute to that mission.”
Fandrich highlighted the need for reimagining business processes around intelligence. “The greatest opportunities won’t come from isolated technology deployments, but from reimagining business processes and operating models around intelligence,” he said. Reynolds added that AI must be integrated into everyday workflows in ways that are practical, scalable and measurable.
Mike Longacre, who joins Autonomize as Head of Transformation, has led enterprise modernization and AI strategy for payers and technology firms, including roles at PwC’s Health Transformation practice, UnitedHealthcare and ConnectureDRX. The new position is intended to help customers accelerate enterprise‑wide adoption, align technology initiatives with business priorities and unlock the full value of AI‑driven transformation.
“Many organizations know where they want to go with AI, but the path from pilot to enterprise‑wide transformation remains challenging,” Longacre said. “Success requires aligning people, processes, governance, technology and culture around a shared vision. I’m excited to help our customers unlock the full potential of AI by translating innovation into sustainable operational change.”
Autonomize’s platform is described as an AI operating layer built exclusively for healthcare enterprises, offering AI agents, workflow intelligence and domain expertise. The company emphasizes enterprise‑grade governance, security, compliance and explainability, and positions itself as a bridge between fragmented data and institutional knowledge.
The expansion of the advisory board and the creation of the Head of Transformation role signal Autonomize’s commitment to the next phase of AI in healthcare, which the company views as defined by responsible, scalable and measurable operationalization rather than by technological novelty alone.
At present, Autonomize continues to develop its platform, with recent updates to the Knowledge Center and the release of version 3 of its Intelligence Platform. The company’s leadership team remains focused on helping health systems move beyond pilots and achieve measurable clinical, operational and financial impact from AI investments.
The company’s latest moves come amid a broader industry push to embed AI into core operations, as payers and providers face mounting pressure to improve efficiency, reduce administrative burden and enhance patient outcomes. Autonomize’s expanded leadership team and new transformation role aim to address the gap between AI innovation and real‑world impact.
As the healthcare sector seeks to scale AI responsibly, Autonomize’s expanded advisory board and transformation leadership position the company to guide organizations through the complex journey from experimentation to enterprise‑wide adoption.
